The global primary sclerosing cholangitis (PSC) market is on an impressive growth trajectory, with forecasts estimating a market valuation of USD 314.26 million by 2033. This robust expansion is ...

The global non-small cell lung carcinoma market is poised for significant expansion over the next decade, according to new industry projections. Valued at USD 8.25 billion in 2023, the NSCLC market is ...

The global amyotrophic lateral sclerosis market is on an upward trajectory, demonstrating significant potential for growth and innovation. According to the latest insights from Future Market Insights ...

The global checkpoint inhibitor refractory cancer market is experiencing significant growth, with an expected valuation of USD 38.69 billion in 2023. This expansion is fueled by the rising health ...

The global non-small cell lung cancer market is on track for exceptional growth, driven by increasing demand for innovative treatment solutions. According to recent market projections, the market ...

The global CRBSI treatment market is on a significant growth trajectory, projected to experience a compound annual growth rate (CAGR) of 5.4% between 2025 and 2035. This growth is being propelled by ...

The global bullous keratopathy market is forecasted to grow at a compounded annual growth rate (CAGR) of 4.3% from 2023 to 2033, is anticipated, with an anticipated closing value of USD 650 Million by ...

The global pediatric dental market has shown impressive growth over the past decade, and new findings from the latest industry analysis report by Future Market Insights reveal that the pediatric ...

The automated and closed cell therapy processing systems market is experiencing rapid growth, driven by the increasing demand for regenerative medicine and the need for advanced, scalable ...

The fight against cancer has witnessed numerous advancements in medical technology, and one of the most promising developments is brachytherapy. Brachytherapy, a localized radiation therapy, has been ...

ConferenceBioVersys to Host Virtual KOL Event to Discuss BV100 Phase 2 Ventilator Associated Pneumonia (VABP) Study Against Carbapenem Resistant Acinetobacter on May 7, 2025 28.04.2025 / 07:00 ...